U.S. stock futures were mixed this morning, with the Dow futures falling around 100 points on Tuesday.
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) fell sharply in today's pre-market trading after the company announced plans to focus exclusively on autoimmunity and named Beth Harler as CEO. Also, the company stated it will reduce its work force and minimize future spending on R&D for Aplitabart and other oncology candidates.
IGM Biosciences shares dipped 27.2% to $12.05 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
Now Read This:
Image created using artificial intelligence via Midjourney.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
